Breaking News, Promotions & Moves

BioAgilytix Appoints Dr. Linda Robbie as COO

Robbie has more than 25 years of experience with biomarker assay technologies, including 20 years of experience in scientific leadership positions.

Author Image

By: Charlie Sternberg

Associate Editor

BioAgilytix Labs LLC, a contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, has appointed Dr. Linda Robbie as chief operating officer, effective August 9, 2022.   For the past three years, Robbie has served as vice president and general manager of Boston operations, responsible for leading all Bioanalytical Services at BioAgilytix’s Boston, MA Laboratory. During this time, she directed all initiatives relating to science, technology,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters